These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 17448444)
1. Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression. Nilsson LM; Abrahamsson A; Sahlin S; Gustafsson U; Angelin B; Parini P; Einarsson C Biochem Biophys Res Commun; 2007 Jun; 357(3):707-11. PubMed ID: 17448444 [TBL] [Abstract][Full Text] [Related]
2. Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III. Ghosh Laskar M; Eriksson M; Rudling M; Angelin B J Intern Med; 2017 Jun; 281(6):575-585. PubMed ID: 28145001 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the proprotein convertase subtilisin/kexin type 9 in intestinal epithelial cells. Leblond F; Seidah NG; Précourt LP; Delvin E; Dominguez M; Levy E Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G805-15. PubMed ID: 19179626 [TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver. Rudling M; Angelin B; Ståhle L; Reihnér E; Sahlin S; Olivecrona H; Björkhem I; Einarsson C J Clin Endocrinol Metab; 2002 Sep; 87(9):4307-13. PubMed ID: 12213890 [TBL] [Abstract][Full Text] [Related]
5. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol. Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503 [TBL] [Abstract][Full Text] [Related]
6. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways. Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665 [TBL] [Abstract][Full Text] [Related]
7. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat. Kamisako T; Ogawa H; Yamamoto K J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222 [TBL] [Abstract][Full Text] [Related]
8. Hypocholesterolemic effect of daily fisetin supplementation in high fat fed Sprague-Dawley rats. Shin MJ; Cho Y; Moon J; Jeon HJ; Lee SM; Chung JH Food Chem Toxicol; 2013 Jul; 57():84-90. PubMed ID: 23524313 [TBL] [Abstract][Full Text] [Related]
9. Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates. Amano Y; Shimada M; Miura S; Adachi R; Tozawa R Eur J Pharmacol; 2014 Jan; 723():108-15. PubMed ID: 24361308 [TBL] [Abstract][Full Text] [Related]
10. Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans. Persson L; Cao G; Ståhle L; Sjöberg BG; Troutt JS; Konrad RJ; Gälman C; Wallén H; Eriksson M; Hafström I; Lind S; Dahlin M; Amark P; Angelin B; Rudling M Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2666-72. PubMed ID: 20884874 [TBL] [Abstract][Full Text] [Related]
11. Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance. Drouin-Chartier JP; Tremblay AJ; Lemelin V; Lépine MC; Lamarche B; Couture P Diabetes Obes Metab; 2016 Dec; 18(12):1226-1235. PubMed ID: 27460541 [TBL] [Abstract][Full Text] [Related]
12. Effects of Tanshinone IIA on the modulation of miR‑33a and the SREBP‑2/Pcsk9 signaling pathway in hyperlipidemic rats. Jia L; Song N; Yang G; Ma Y; Li X; Lu R; Cao H; Zhang N; Zhu M; Wang J; Leng X; Cao Y; Du Y; Xu Y Mol Med Rep; 2016 Jun; 13(6):4627-35. PubMed ID: 27082100 [TBL] [Abstract][Full Text] [Related]
13. Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression. Parker RA; Garcia R; Ryan CS; Liu X; Shipkova P; Livanov V; Patel P; Ho SP J Lipid Res; 2013 Sep; 54(9):2400-9. PubMed ID: 23614904 [TBL] [Abstract][Full Text] [Related]
14. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes. Langhi C; Le May C; Kourimate S; Caron S; Staels B; Krempf M; Costet P; Cariou B FEBS Lett; 2008 Mar; 582(6):949-55. PubMed ID: 18298956 [TBL] [Abstract][Full Text] [Related]
15. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. Dong B; Wu M; Li H; Kraemer FB; Adeli K; Seidah NG; Park SW; Liu J J Lipid Res; 2010 Jun; 51(6):1486-95. PubMed ID: 20048381 [TBL] [Abstract][Full Text] [Related]
16. Quercetin regulates hepatic cholesterol metabolism by promoting cholesterol-to-bile acid conversion and cholesterol efflux in rats. Zhang M; Xie Z; Gao W; Pu L; Wei J; Guo C Nutr Res; 2016 Mar; 36(3):271-9. PubMed ID: 26923514 [TBL] [Abstract][Full Text] [Related]
17. Importance of proprotein convertase subtilisin/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors. Persson L; Gälman C; Angelin B; Rudling M Endocrinology; 2009 Mar; 150(3):1140-6. PubMed ID: 19008317 [TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic bile acid transporters Ntcp and Bsep expression. Cheng X; Buckley D; Klaassen CD Biochem Pharmacol; 2007 Dec; 74(11):1665-76. PubMed ID: 17897632 [TBL] [Abstract][Full Text] [Related]
19. Onion peel extract increases hepatic low-density lipoprotein receptor and ATP-binding cassette transporter A1 messenger RNA expressions in Sprague-Dawley rats fed a high-fat diet. Lee SM; Moon J; Do HJ; Chung JH; Lee KH; Cha YJ; Shin MJ Nutr Res; 2012 Mar; 32(3):210-7. PubMed ID: 22464808 [TBL] [Abstract][Full Text] [Related]
20. Impacts of ezetimibe on PCSK9 in rats: study on the expression in different organs and the potential mechanisms. Xu RX; Liu J; Li XL; Li S; Zhang Y; Jia YJ; Sun J; Li JJ J Transl Med; 2015 Mar; 13():87. PubMed ID: 25889684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]